MedPath

Recombinant Human Coagulation Factor VIIa

Generic Name
Recombinant Human Coagulation Factor VIIa
Indication

用于下列患者群体的出血发作及预防在外科手术过程中或有创操作中的出血。1.凝血因子Ⅷ或Ⅸ的抑制物>5BU的先天性血友病患者;2.预计对注射凝血因子Ⅷ或凝血因子Ⅸ,具有高记忆应答的先天性血友病患者;3.获得性血友病患者;4.先天性FⅦ缺乏症患者;5.具有GPⅡb-Ⅲa和/或HLA抗体和既往或现在对血小板输注无效或不佳的血小板无力症患者。

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Phase 1
Conditions
Hemophilia B With Inhibitor
Hemophilia A With Inhibitor
Interventions
Drug: TQG203/NovoSeven®
First Posted Date
2021-02-24
Last Posted Date
2021-02-24
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Target Recruit Count
24
Registration Number
NCT04768699
Locations
🇨🇳

Hematology Hospital of Chinese Academy of Medical Sciences, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath